BU-NOT-SET

CONTACT US
Stability studies are ever changing: Outsourcing as a viable option
  • Analytical chemistry
Development workers
Insight
Navigating the regulatory landscape for controlled substances
  • Drug substance
Man at work
Insight
How to speed up vaccine development and production
  • Manufacturing
Vaccine
eBook
Reducing time to market with analytical chemistry
  • Analytical chemistry
Workers
Insight
Serialisation – Looking for value-added opportunities
  • Manufacturing
Eyes
Insight
Outlining the key steps to analytical method development
  • Analytical chemistry
Eyes
Insight
Outsourcing formulation development & manufacturing
  • Drug product
Eyes
Insight
Complying with Annex 1: Things to bear in mind
  • Drug product
Eyes
Insight
Optimising a prolonged release fixed dose combination product
  • Drug product
pills
Case study
Insight
  • Biologics
Overcoming the challenges surrounding manufacturing oncolytic viruses
Insight
  • Drug product
  • Industry trends
Insights from DCAT Week: Exploring drug storage, drug dosage and the supply chain
White paper
  • Analytical chemistry
  • Drug product
Developing a robust dissolution method for low-dose formulations
Report
  • Sustainability
Sustainability report 2022
Insight
  • Drug product
  • Industry trends
Navigating the changing oral solid dose landscape
Insight
  • Drug product
  • Manufacturing
The opportunities and obstacles of filling and packaging pre-filled syringes
Insight
  • Drug product
  • Industry trends
Tips for facilitating a successful tech transfer between sponsor and CDMO
Insight
  • Drug product
  • Industry trends
Alternative drug delivery formulation & device expertise
Insight
  • Industry trends
The 3 key trends shaping the CDMO industry in 2023 and beyond